Senega Root

Generic name: Polygala Senega L.
Brand names: Milkwort, Mountain Flax, Polygalae Radix, Rattlesnake Root, Seneca Snakeroot, Tenuigenin

Usage of Senega Root

Antitussive effects

The antitussive effect of senega root has generally been attributed to the saponin content of the plant, which is consistent with the general detergent property of saponins in breaking up phlegm.(van Wyk 2004) In addition, senega is thought to act by irritation of the gastric mucosa followed by a reflex action, which stimulates an increase in bronChial mucous gland secretion. However, most of the available information about senega's antitussive properties is anecdotal.

Animal and in vitro data

In a study of anesthetized dogs, senega syrup dosed orally at 3 mL/kg (about 90 mg/kg) increased the volume output of respiratory tract fluid within 5 minutes of administration; the increase continued at 30 minutes following administration.(Misawa 1980)

Clinical data

In one study, a fluid extract of senega root reduced mucus viscosity in patients with bronchiectasis.(WHO 2004)

Cancer

Animal and in vitro data

In mice inoculated with sarcoma S180 cells, the senega saponin senegin III dosed at 2.5 mg/kg inhibited tumor growth in a manner similar to cisplatin. In addition, the combination of senegin III with cisplatin resulted in greater growth inhibition compared with the control group.(Arai 2011)

In in vitro and an in vivo models in mice, P. senega was beneficial in the treatment of lung cancer. Administration of senega 50 and 100 mg/kg in mice with long-term exposure to a carcinogen modulated the expression of signal proteins.(Paul 2010) Similarly, an ethanolic root extract of P. senega reduced DNA damage as well as tumor nodules and tumor growth in mice with benzo[a]pyrene-induced lung cancer.(Paul 2011) Nanoencapsulation of an ethanolic root extract of P. senega was associated with greater inhibition of cancer cell growth, better bioavailability, and increased cellular entry compared with the non-nanoencapsulated ethanolic root extract of P. senega.(Paul 2011)

Hypoglycemic effects

Animal and in vitro data

In studies evaluating the hypoglycemic effects of senega saponins in mice with and without diabetes, hypoglycemic activity was observed in normal and diabetic mice, but not in mice with streptozotocin-induced diabetes.(Kako 1995, Kako 1996, Kako 1997, Yoshikawa 1995, Yoshikawa 1995, Yoshikawa 1996) Thus, these compounds have activity relevant to non–insulin-Dependent diabetes. This activity is most potent when the saponins are injected intraperitoneally but can also be detected with higher oral doses. The same saponins also substantially reduced alcohol absorption when given orally to rats 1 hour before alcohol consumption.(Yoshikawa 1995, Yoshikawa 1996, Yoshikawa 1995)

In a study investigating an aqueous extract of the related species P. tenuifolia, a potent blocking effect on inflammatory processes in cultured mouse astrocytes was observed. Substance P– and lipopolysaccharide-induced production of tumor necrosis factor and interleukin-1 (IL-1) was blocked by a P. tenuifolia extract at low concentrations.(Kim 1998) It is possible that a systemic anti-inflammatory effect may be the result of a similar mechanism.

No biological activity has been reported for the oligosaccharides of senega root. Senegose A was inactive in the previously described hypoglycemia model.(Kako 1997)

Immunological effects

Animal and in vitro data

In a murine model, P. senega saponins increased antibody response to ovalbumin antigens in mice. These effects were similar to those of saponins from Q. saponaria but were less toxic, suggesting a potential role as an adjuvant in vaccines.(Katselis 2007) Another study demonstrated similar effects in mice immunized with ovalbumin, with no P. senega saponin effect detected 10 days after immunization; in another arm of this study, P. senega saponins increased the immunoglobulin G response to rotavirus in immunized hens.(Estrada 2000) In an in vitro study, senega saponins exerted antiangiogenic activity against human umbilical vein endothelial cells.(Arai 2011)

A cell-screening assay of several P. senega extracts revealed dose-dependent anti-inflammatory effects, such as reductions in levels of IL-1beta, IL-6, and tumor necrosis factor alpha.(Van 2009)

Other uses

Tenuigenin, the major active component of P. senega and other Polygala species, has been shown to be a significant inhibitor of NF-kappaB and capable of preventing IL-1beta-induced inflammation in human osteoarthritis chondrocytes. Significant decreases in many other pro-inflammatory cytokines (ie, TNF-alpha, IL-1beta, IL-6, IL-12, PGE-2) and enzymes (ie, iNOS, COX-2) have also been observed with tenuigenin, P. japonica, P. sabulosa, P. molluginifolia, and other species. Findings in animal models of neuroinflammation, pleurisy, peritonitis, pneumonia, liver, and kidney injury further support the anti-inflammatory effects of Polygala species and extracts.(Lacaille-Dubois 2020)

Neuroprotection against degeneration of dopaminergic neurons in a mouse model of Parkinson disease was documented for tenuigenin, which also improved neuroplasticity in vitro by potentiating basic synaptic transmission via regulation of presynaptic intracellular calcium. In an Alzheimer murine model, tenuigenin significantly improved memory-related behaviors and cognitive dysfunction via dose-dependent antioxidant effects in the hippocampus. Improvements in memory and cognitive function were also demonstrated with tenuigenin in a menopausal mouse model.(Lacaille-Dubois 2020)

Senega Root side effects

High doses of powdered senega root (more than 1 g) or tincture are emetic and irritating to the GI tract.(Blumenthal 1998) The use of senega root is contraindicated during pregnancy, and in peptic ulcer disease or inflammatory bowel disease.(Grieve 1931) Senega may exacerbate inflammatory conditions of the GI tract.

Before taking Senega Root

Avoid use. Emmenagogue and uterine stimulant action has been documented.(Brinker 1998, Ernst 2002)

How to use Senega Root

Root

1 to 3 g/day.(Blumenthal 1998, Claus 1956)

Fluid extract

1.5 to 3 g/day(Brinker 1998) or 0.3 to 1 mL/day.(van Wyk 2004)

Tincture

2.5 to 7.5 g/day(Blumenthal 1998) or 2.5 to 5 mL/day.(van Wyk 2004)

Warnings

When investigated for their immunological potential as adjuvants in vaccinations, saponin fractions of P. senega were less toxic than those from Q. saponaria, which have traditionally been used as adjuvants for veterinary vaccines.(Estrada 2000)

What other drugs will affect Senega Root

None well documented.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords